JESSICA BORDERIEUX: Open Payments
NPI 1407845654 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,796 in 116 payments from 16 companies in 2025. Trend: 2023 $2,804 · 2024 $2,370 · 2025 $2,796
Food & beverage: $2,727Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $442 |
| Incyte Corporation | 13 | $361 |
| UCB, Inc. | 8 | $329 |
| ABBVIE INC. | 20 | $301 |
| Organon LLC | 10 | $264 |
| Novartis Pharmaceuticals Corporation | 14 | $262 |
| Galderma Laboratories, L.P. | 10 | $259 |
| Lilly USA, LLC | 5 | $180 |
| Amgen Inc. | 4 | $78 |
| PFIZER INC. | 4 | $77 |
Products named: TREMFYA, Opzelura, Bimzelx, SKYRIZI, NEMLUVIO, COSENTYX, VTAMA, TALTZ.
Industry payments across PA — which companies pay providers there.
